XML 44 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Segment Reporting Information By Segment
A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
 
2017
 
2016
 
2017
 
2016
 
 
 
 
(restated)
 
 
 
(restated)
Net sales
 
 
 
 
 
 
 
 
Interventional Cardiology
 
$
589

 
$
565

 
$
1,806

 
$
1,705

Peripheral Interventions
 
268

 
256

 
812

 
764

Cardiovascular
 
857

 
821

 
2,618

 
2,469

 
 
 
 
 
 
 
 
 
Cardiac Rhythm Management
 
461

 
465

 
1,417

 
1,380

Electrophysiology
 
71

 
60

 
203

 
180

Rhythm Management
 
532

 
525

 
1,620

 
1,560

 
 
 
 
 
 
 
 
 
Endoscopy
 
402

 
365

 
1,194

 
1,065

Urology and Pelvic Health
 
272

 
247

 
819

 
732

Neuromodulation
 
153

 
138

 
449

 
395

MedSurg
 
827

 
750

 
2,462

 
2,192

Net sales allocated to reportable segments
 
2,216

 
2,096

 
6,700

 
6,221

Impact of foreign currency fluctuations
 
6

 
9

 
(60
)
 
(26
)
 
 
$
2,222

 
$
2,105

 
$
6,640

 
$
6,195

 
 
 
 
 
 
 
 
 
Income (loss) before income taxes
 
 
 
 
 
 
 
 
Cardiovascular
 
$
243

 
$
247

 
$
756

 
$
751

Rhythm Management
 
103

 
90

 
319

 
231

MedSurg
 
272

 
234

 
781

 
682

Operating income allocated to reportable segments
 
618

 
571

 
1,856

 
1,664

Corporate expenses and currency exchange
 
(60
)
 
(60
)
 
(215
)
 
(162
)
Intangible asset impairment charges, acquisition-related, restructuring- and restructuring-related, and litigation-related net credits (charges)
 
(42
)
 
(27
)
 
(250
)
 
(787
)
Amortization expense
 
(139
)
 
(136
)
 
(424
)
 
(408
)
Operating income (loss)
 
377

 
348

 
967

 
307

Other expense, net
 
(68
)
 
(91
)
 
(261
)
 
(219
)
Income (loss) before income taxes
 
$
309

 
$
257

 
$
706

 
$
88